898 abstracts found.



Results filter

Cell-free plasma markers of breast cancer in young women and women at high risk

Year:

Session type:

Nuha Almull1, Shona Elshaw1, David Guttery1, Karen Page1, Howard Pringle1, Julian Barwell2, Jacqueline Shaw1,
1University of Leicester, Leicester, UK,2University of Leicester, Leicester, UK,3University of Leicester, Leicester, UK,4University of Leicester, Leicester, UK,5University of Leicester, Leicester, UK,6University Hospital of Leicester, Leicester, UK,7University of Leicester, Leicester, UK

Recruitment challenges in early phase cancer clinical trials: an analysis from the Drug Development Office, Cancer Research UK

Year:

Session type:

Philip Ross1,
1Drug Development Office Cancer Research UK, London, UK

Risk factors for emergency presentation with lung and colorectal cancers: a systematic review

Year:

Session type:

Elizabeth Mitchell1, Benjamin Pickwell-Smith2, Una Macleod3,
1University of Leeds, Leeds, UK,2Oxford University Hospitals, Oxford, UK,3Hull York Medical School, Hull, UK

Innovative target identification for oral and oropharyngeal cancer therapeutics

Year:

Session type:

Matthew Davidson1, Lynn McGarry1, Daniel James1, Emma Shanks1,
1CRUK Beatson Institute, Glasgow, UK

Expression of tartrate-resistant acid phosphatase differs in benign and malignant canine melanomas

Year:

Session type:

Rachael Nielsen1, Michael Day1, Alison Hayman1,
1School of Veterinary Science, University of Bristol, Langford, Bristol, UK

A Product of Independent beta Probabilities dose Escalation (PIPE) design for dual-agent Phase I trials

Year:

Session type:

Adrian Mander1, Michael Sweeting1,
1MRC Biostatistics Unit, Cambridge, UK

From trial to practice: the Northern Ireland Cancer Centre experience with Abiraterone Acetate in men with metastatic castration resistant prostate cancer

Year:

Session type:

Aya El Helali1, Prantik Das1, Suneil Jain1, Darren Mitchell1, Lin Shum1, David Stewart1, Joe O'Sullivan1,
1Belfast City Hospital, Belfast, Co. Antrim, UK

Evidence around criteria for selecting ovarian cancer patients for BRCA mutation testing – findings from the literature and guidelines review

Year:

Session type:

Diana Eccles1, Encarna Gomez Garcia2, Judith Balmaña3, Birgit Ehlken4, Claudia Schroeder4, Joe Clune5, Ceri Hirst6, Danielle Potter6, Jerzy E Tyczynski6,
1Cancer Sciences Academic Unit Faculty of Medicine, University of Southampton and Wessex Regional Genetics Service, Southampton, UK,2Dept of Clinical Genetics, Maastricht UMC+, Maastricht, The Netherlands,3Medical Oncology Dept, Familial Cancer Program, Barcelona, Spain,4IMS Health, Munich, Germany,5Global Product and Portfolio Strategy, AstraZeneca, Melbourn, UK,6Observational Research Center, AstraZeneca, Gaithersburg, MD, USA

Page 90 of 90« First...25...90